Q-linea AB Company Description

Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom and European Union.

The company offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, including a sample preparation cartridge and an AST disc, used with the Frozen insert.

It also develops Podler, a portable blood culture unit for incubating and detecting growth in blood bottles.

The company serves physicians, hospitals, laboratories, healthcare payers, and the medical profession.

The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.

Q-linea AB (publ)

Country	Sweden
Founded	2007
Industry	Medical Devices
Sector	Healthcare
Employees	94
CEO	Stuart Gander

Contact Details

Address: Dag Hammarskjölds väg 52 A Uppsala, 752 37 Sweden
Phone	46 18 444 3610
Website	qlinea.com

Stock Details

Ticker Symbol	QLINEA
Exchange	Nasdaq Stockholm
Fiscal Year	January - December
Reporting Currency	SEK
ISIN Number	SE0011527845
SIC Code	3845

Key Executives

Name	Position
Stuart Gander	Chief Executive Officer
Anders Ljunggren	Managing Director
Christer Samuelsson	Chief Financial Officer and IR
Henrik Jacobson	Chief Operating Officer
Ulrika Stolpe	HR Manager
Jonas Melin	Director Product Development
Thomas Fritz	Chief Commercial Officer
Victoria Lerneryd	Manager of QA/RA